-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL - ANNOUNCES EMA VALIDATION OF MAA FOR REBISUFLIGENE ETISPARVOVEC GENE THERAPY

路透·10/02/2026 06:03:32

請登錄查看新聞詳情